HiFiBio
Home - HiFiBiO Therapeutics
Cambridge · Founded 2013 · $179.5M raised
- Headquarters
- Cambridge
- Employees
- 51–200
- Founded
- 2013
- Business Model
- B2B
- Website
- hifibio.com
- Total Funding
- $179.5M
- Last Round
- $75.0M Series DJun 2021
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
HiFiBiO Therapeutics is a multinational biotherapeutics company that integrates single-cell profiling technologies with deep biological expertise to discover and advance antibody drugs for cancer and autoimmune disorders. The company operates facilities across Cambridge, Massachusetts, Paris, France, and Hangzhou, China, pursuing curative immunotherapies for patients with high unmet medical needs.
Summary
HiFiBio is a Biotech company based in Cambridge, founded in 2013. It has raised $179.5M in total across 3 rounds, most recently a $75.0M Series D round in Jun 2021. Investors include Mirae Asset Financial Group, Kite Ventures and Sequoia Capital.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2021
Sign up to see all 3 events
Funding: Series B through Series D. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/hifibio"><img src="https://indexed.vc/api/badge/company/hifibio" alt="HiFiBio on Indexed.vc" width="260" height="76" /></a>